352 related articles for article (PubMed ID: 27213312)
1. Novel Radioligands for Cyclic Nucleotide Phosphodiesterase Imaging with Positron Emission Tomography: An Update on Developments Since 2012.
Schröder S; Wenzel B; Deuther-Conrad W; Scheunemann M; Brust P
Molecules; 2016 May; 21(5):. PubMed ID: 27213312
[TBL] [Abstract][Full Text] [Related]
2. Challenges on Cyclic Nucleotide Phosphodiesterases Imaging with Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights since 2016.
Schröder S; Scheunemann M; Wenzel B; Brust P
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917199
[TBL] [Abstract][Full Text] [Related]
3. Carboxyamidotriazole: a novel inhibitor of both cAMP-phosphodiesterases and cGMP-phosphodiesterases.
Guo L; Luo L; Ju R; Chen C; Zhu L; Li J; Yu X; Ye C; Zhang D
Eur J Pharmacol; 2015 Jan; 746():14-21. PubMed ID: 25446933
[TBL] [Abstract][Full Text] [Related]
4. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295
[TBL] [Abstract][Full Text] [Related]
5. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
Cheng J; Grande JP
Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in positron emission tomography (PET) radiotracers for imaging phosphodiesterases.
Andrés JI; De Angelis M; Alcázar J; Celen S; Bormans G
Curr Top Med Chem; 2012; 12(11):1224-36. PubMed ID: 22571785
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Phosphodiesterases and Their Modulation for Treating Heart Disease.
Kim GE; Kass DA
Handb Exp Pharmacol; 2017; 243():249-269. PubMed ID: 27787716
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterases in neurodegenerative disorders.
Bollen E; Prickaerts J
IUBMB Life; 2012 Dec; 64(12):965-70. PubMed ID: 23129425
[TBL] [Abstract][Full Text] [Related]
9. Natural Molecules as Talented Inhibitors of Nucleotide Pyrophosphatases/ Phosphodiesterases (PDEs).
Orhan IE; Rauf A; Saleem M; Khalil AA
Curr Top Med Chem; 2022; 22(3):209-228. PubMed ID: 34503407
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular genetics of the phosphodiesterases (PDEs).
Azevedo MF; Faucz FR; Bimpaki E; Horvath A; Levy I; de Alexandre RB; Ahmad F; Manganiello V; Stratakis CA
Endocr Rev; 2014 Apr; 35(2):195-233. PubMed ID: 24311737
[TBL] [Abstract][Full Text] [Related]
11. Cyclic adenosine monophosphate and cyclic guanosine monophosphate-phosphodiesterase isoenzymes in human vagina: relation to nitric oxide synthase isoforms and vasoactive intestinal polypeptide-containing nerves.
Uckert S; Oelke M; Waldkirch E; Stief CG; Albrecht K; Tröger HD; Jonas U; Andersson KE; Hedlund P
Urology; 2005 Mar; 65(3):604-10. PubMed ID: 15780401
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel cAMP-binding, cAMP-specific cyclic nucleotide phosphodiesterase (TcrPDEB1) from Trypanosoma cruzi.
Díaz-Benjumea R; Laxman S; Hinds TR; Beavo JA; Rascón A
Biochem J; 2006 Oct; 399(2):305-14. PubMed ID: 16776650
[TBL] [Abstract][Full Text] [Related]
13. Real-time monitoring of phosphodiesterase inhibition in intact cells.
Herget S; Lohse MJ; Nikolaev VO
Cell Signal; 2008 Aug; 20(8):1423-31. PubMed ID: 18467075
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase Inhibitors as a Therapeutic Approach to Neuroprotection and Repair.
Knott EP; Assi M; Rao SN; Ghosh M; Pearse DD
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28338622
[TBL] [Abstract][Full Text] [Related]
15. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
[TBL] [Abstract][Full Text] [Related]
16. An update on cyclic nucleotide phosphodiesterase (PDE) inhibitors: phosphodiesterases and drug selectivity.
Gupta R; Kumar G; Kumar RS
Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):101-18. PubMed ID: 15834463
[TBL] [Abstract][Full Text] [Related]
17. [Cyclic nucleotide phosphodiesterases: role in the heart and therapeutic perspectives].
Bedioune I; Bobin P; Karam S; Lindner M; Mika D; Lechêne P; Leroy J; Fischmeister R; Vandecasteele G
Biol Aujourdhui; 2016; 210(3):127-138. PubMed ID: 27813474
[TBL] [Abstract][Full Text] [Related]
18. The Construction and Application of a New Screening Method for Phosphodiesterase Inhibitors.
Gao C; Wang Z; Liu X; Sun R; Ma S; Ma Z; Wang Q; Li G; Zhang HT
Biosensors (Basel); 2024 May; 14(5):. PubMed ID: 38785726
[TBL] [Abstract][Full Text] [Related]
19. Role of Cyclic Nucleotide Phosphodiesterases During Meiotic Resumption From Diplotene Arrest in Mammalian Oocytes.
Gupta A; Tiwari M; Prasad S; Chaube SK
J Cell Biochem; 2017 Mar; 118(3):446-452. PubMed ID: 27662514
[TBL] [Abstract][Full Text] [Related]
20. Age-associated changes in content of cyclic adenosine-3', 5'-monophosphate (cAMP), cyclic guanosine-3',5'-monophosphate (cGMP) and in activity of phosphodiesterase-cAM (pDE-cAM) in spleen T-lymphocytes from C3HA mice.
Kostromin AP; Berdyshev GD; Demidov SV; Kuibeda VV
Z Alternsforsch; 1984; 39(6):351-5. PubMed ID: 6099007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
